atrial appendage Search Results


percutaneous laa trans-catheter occlusion plaato  (Appriva Medical Inc)
90
Appriva Medical Inc percutaneous laa trans-catheter occlusion plaato
Pre-surgery echo of <t>left</t> <t>atrial</t> <t>appendage</t>
Percutaneous Laa Trans Catheter Occlusion Plaato, supplied by Appriva Medical Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atrial+appendage/pmc03570900-25-15-19?v=Appriva+Medical+Inc
Average 90 stars, based on 1 article reviews
percutaneous laa trans-catheter occlusion plaato - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
right atrial appendages  (Herzzentrum Dresden)
90
Herzzentrum Dresden right atrial appendages
Pre-surgery echo of <t>left</t> <t>atrial</t> <t>appendage</t>
Right Atrial Appendages, supplied by Herzzentrum Dresden, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atrial+appendage/pmc08487716__res___129___804___s001-3-0-9?v=Herzzentrum+Dresden
Average 90 stars, based on 1 article reviews
right atrial appendages - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
modified occlutech laa closure device  (Occlutech GmbH)
90
Occlutech GmbH modified occlutech laa closure device
Occlutech Plus <t>LAA</t> closure device and delivery system. (A) <t>The</t> <t>modified</t> Occlutech LAA closure device consists of a proximal (PU membrane covered) and a distal (nitinol mesh) part. Distal positioned loops and newly developed anchors situated between the proximal and distal device parts secure anchoring within the LAA. The nitinol mesh has self-expanding properties ensuring self-modeling of the device within the LAA. The polyurethane (PU) covering serves as barrier excluding blood flow from the LA to the LAA. The connection hub serves as docking for the delivery system. B) Comparison of new device characteristics compared to the predecessor. C) Delivery system: the dilator (1) made from smooth conformable low friction radio-opaque material is inserted into the steerable delivery sheet (2) consisting of a thin braided wall and a soft flexible tip allowing bidirectional deflection up to 180°. The sheath has a hemostatic valve and can be connected by an adapter to the loader (4) made of transparent low friction material to allow inspection for air bubbles after pulling the occluder into the loader. Permission for usage of the image granted by OCCLUTECH Holding AG.
Modified Occlutech Laa Closure Device, supplied by Occlutech GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atrial+appendage/pmc07862256-45-12-11?v=Occlutech+GmbH
Average 90 stars, based on 1 article reviews
modified occlutech laa closure device - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
atriclip gillinov-cosgrove left atrial appendage exclusion system  (AtriCure Inc)
90
AtriCure Inc atriclip gillinov-cosgrove left atrial appendage exclusion system
Occlutech Plus <t>LAA</t> closure device and delivery system. (A) <t>The</t> <t>modified</t> Occlutech LAA closure device consists of a proximal (PU membrane covered) and a distal (nitinol mesh) part. Distal positioned loops and newly developed anchors situated between the proximal and distal device parts secure anchoring within the LAA. The nitinol mesh has self-expanding properties ensuring self-modeling of the device within the LAA. The polyurethane (PU) covering serves as barrier excluding blood flow from the LA to the LAA. The connection hub serves as docking for the delivery system. B) Comparison of new device characteristics compared to the predecessor. C) Delivery system: the dilator (1) made from smooth conformable low friction radio-opaque material is inserted into the steerable delivery sheet (2) consisting of a thin braided wall and a soft flexible tip allowing bidirectional deflection up to 180°. The sheath has a hemostatic valve and can be connected by an adapter to the loader (4) made of transparent low friction material to allow inspection for air bubbles after pulling the occluder into the loader. Permission for usage of the image granted by OCCLUTECH Holding AG.
Atriclip Gillinov Cosgrove Left Atrial Appendage Exclusion System, supplied by AtriCure Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atrial+appendage/pm24585551-135-19-18?v=AtriCure+Inc
Average 90 stars, based on 1 article reviews
atriclip gillinov-cosgrove left atrial appendage exclusion system - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
percutaneous closure of the left atrial appendage n 2405-500x  (UCLA Health System)
90
UCLA Health System percutaneous closure of the left atrial appendage n 2405-500x
Occlutech Plus <t>LAA</t> closure device and delivery system. (A) <t>The</t> <t>modified</t> Occlutech LAA closure device consists of a proximal (PU membrane covered) and a distal (nitinol mesh) part. Distal positioned loops and newly developed anchors situated between the proximal and distal device parts secure anchoring within the LAA. The nitinol mesh has self-expanding properties ensuring self-modeling of the device within the LAA. The polyurethane (PU) covering serves as barrier excluding blood flow from the LA to the LAA. The connection hub serves as docking for the delivery system. B) Comparison of new device characteristics compared to the predecessor. C) Delivery system: the dilator (1) made from smooth conformable low friction radio-opaque material is inserted into the steerable delivery sheet (2) consisting of a thin braided wall and a soft flexible tip allowing bidirectional deflection up to 180°. The sheath has a hemostatic valve and can be connected by an adapter to the loader (4) made of transparent low friction material to allow inspection for air bubbles after pulling the occluder into the loader. Permission for usage of the image granted by OCCLUTECH Holding AG.
Percutaneous Closure Of The Left Atrial Appendage N 2405 500x, supplied by UCLA Health System, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atrial+appendage/pm34949433-31-12-26?v=UCLA+Health+System
Average 90 stars, based on 1 article reviews
percutaneous closure of the left atrial appendage n 2405-500x - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
plaato laa occlusion system  (ev3 Endovascular)
90
ev3 Endovascular plaato laa occlusion system
Occlutech Plus <t>LAA</t> closure device and delivery system. (A) <t>The</t> <t>modified</t> Occlutech LAA closure device consists of a proximal (PU membrane covered) and a distal (nitinol mesh) part. Distal positioned loops and newly developed anchors situated between the proximal and distal device parts secure anchoring within the LAA. The nitinol mesh has self-expanding properties ensuring self-modeling of the device within the LAA. The polyurethane (PU) covering serves as barrier excluding blood flow from the LA to the LAA. The connection hub serves as docking for the delivery system. B) Comparison of new device characteristics compared to the predecessor. C) Delivery system: the dilator (1) made from smooth conformable low friction radio-opaque material is inserted into the steerable delivery sheet (2) consisting of a thin braided wall and a soft flexible tip allowing bidirectional deflection up to 180°. The sheath has a hemostatic valve and can be connected by an adapter to the loader (4) made of transparent low friction material to allow inspection for air bubbles after pulling the occluder into the loader. Permission for usage of the image granted by OCCLUTECH Holding AG.
Plaato Laa Occlusion System, supplied by ev3 Endovascular, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atrial+appendage/pm23668912-56-1-5?v=ev3+Endovascular
Average 90 stars, based on 1 article reviews
plaato laa occlusion system - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
feasibility and safety of the percutaneous and non-fluoroscopic procedure for left atrial appendage closure  (Guangzhi Corporation)
90
Guangzhi Corporation feasibility and safety of the percutaneous and non-fluoroscopic procedure for left atrial appendage closure
Occlutech Plus <t>LAA</t> closure device and delivery system. (A) <t>The</t> <t>modified</t> Occlutech LAA closure device consists of a proximal (PU membrane covered) and a distal (nitinol mesh) part. Distal positioned loops and newly developed anchors situated between the proximal and distal device parts secure anchoring within the LAA. The nitinol mesh has self-expanding properties ensuring self-modeling of the device within the LAA. The polyurethane (PU) covering serves as barrier excluding blood flow from the LA to the LAA. The connection hub serves as docking for the delivery system. B) Comparison of new device characteristics compared to the predecessor. C) Delivery system: the dilator (1) made from smooth conformable low friction radio-opaque material is inserted into the steerable delivery sheet (2) consisting of a thin braided wall and a soft flexible tip allowing bidirectional deflection up to 180°. The sheath has a hemostatic valve and can be connected by an adapter to the loader (4) made of transparent low friction material to allow inspection for air bubbles after pulling the occluder into the loader. Permission for usage of the image granted by OCCLUTECH Holding AG.
Feasibility And Safety Of The Percutaneous And Non Fluoroscopic Procedure For Left Atrial Appendage Closure, supplied by Guangzhi Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atrial+appendage/pmc10498255__qims___13___09___5831___coif-64-9-8?v=Guangzhi+Corporation
Average 90 stars, based on 1 article reviews
feasibility and safety of the percutaneous and non-fluoroscopic procedure for left atrial appendage closure - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
left atrial appendage occluder  (Coherex Medical Inc)
90
Coherex Medical Inc left atrial appendage occluder
Occlutech Plus <t>LAA</t> closure device and delivery system. (A) <t>The</t> <t>modified</t> Occlutech LAA closure device consists of a proximal (PU membrane covered) and a distal (nitinol mesh) part. Distal positioned loops and newly developed anchors situated between the proximal and distal device parts secure anchoring within the LAA. The nitinol mesh has self-expanding properties ensuring self-modeling of the device within the LAA. The polyurethane (PU) covering serves as barrier excluding blood flow from the LA to the LAA. The connection hub serves as docking for the delivery system. B) Comparison of new device characteristics compared to the predecessor. C) Delivery system: the dilator (1) made from smooth conformable low friction radio-opaque material is inserted into the steerable delivery sheet (2) consisting of a thin braided wall and a soft flexible tip allowing bidirectional deflection up to 180°. The sheath has a hemostatic valve and can be connected by an adapter to the loader (4) made of transparent low friction material to allow inspection for air bubbles after pulling the occluder into the loader. Permission for usage of the image granted by OCCLUTECH Holding AG.
Left Atrial Appendage Occluder, supplied by Coherex Medical Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atrial+appendage/pmc05153038-68-9-7?v=Coherex+Medical+Inc
Average 90 stars, based on 1 article reviews
left atrial appendage occluder - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
lariat left atrial appendage ligation  (AtriCure Inc)
90
AtriCure Inc lariat left atrial appendage ligation
Occlutech Plus <t>LAA</t> closure device and delivery system. (A) <t>The</t> <t>modified</t> Occlutech LAA closure device consists of a proximal (PU membrane covered) and a distal (nitinol mesh) part. Distal positioned loops and newly developed anchors situated between the proximal and distal device parts secure anchoring within the LAA. The nitinol mesh has self-expanding properties ensuring self-modeling of the device within the LAA. The polyurethane (PU) covering serves as barrier excluding blood flow from the LA to the LAA. The connection hub serves as docking for the delivery system. B) Comparison of new device characteristics compared to the predecessor. C) Delivery system: the dilator (1) made from smooth conformable low friction radio-opaque material is inserted into the steerable delivery sheet (2) consisting of a thin braided wall and a soft flexible tip allowing bidirectional deflection up to 180°. The sheath has a hemostatic valve and can be connected by an adapter to the loader (4) made of transparent low friction material to allow inspection for air bubbles after pulling the occluder into the loader. Permission for usage of the image granted by OCCLUTECH Holding AG.
Lariat Left Atrial Appendage Ligation, supplied by AtriCure Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atrial+appendage/pm38563835-28-16-13?v=AtriCure+Inc
Average 90 stars, based on 1 article reviews
lariat left atrial appendage ligation - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
device related to left atrial appendage closure  (AtriCure Inc)
90
AtriCure Inc device related to left atrial appendage closure
Occlutech Plus <t>LAA</t> closure device and delivery system. (A) <t>The</t> <t>modified</t> Occlutech LAA closure device consists of a proximal (PU membrane covered) and a distal (nitinol mesh) part. Distal positioned loops and newly developed anchors situated between the proximal and distal device parts secure anchoring within the LAA. The nitinol mesh has self-expanding properties ensuring self-modeling of the device within the LAA. The polyurethane (PU) covering serves as barrier excluding blood flow from the LA to the LAA. The connection hub serves as docking for the delivery system. B) Comparison of new device characteristics compared to the predecessor. C) Delivery system: the dilator (1) made from smooth conformable low friction radio-opaque material is inserted into the steerable delivery sheet (2) consisting of a thin braided wall and a soft flexible tip allowing bidirectional deflection up to 180°. The sheath has a hemostatic valve and can be connected by an adapter to the loader (4) made of transparent low friction material to allow inspection for air bubbles after pulling the occluder into the loader. Permission for usage of the image granted by OCCLUTECH Holding AG.
Device Related To Left Atrial Appendage Closure, supplied by AtriCure Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atrial+appendage/pm28242017-4-11-8?v=AtriCure+Inc
Average 90 stars, based on 1 article reviews
device related to left atrial appendage closure - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
left atrial appendage closure device  (Occlutech GmbH)
90
Occlutech GmbH left atrial appendage closure device
Technical properties of LAA <t> closure </t> during follow-up.
Left Atrial Appendage Closure Device, supplied by Occlutech GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atrial+appendage/pmc07862256-72-4-8?v=Occlutech+GmbH
Average 90 stars, based on 1 article reviews
left atrial appendage closure device - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
wavecrest i left atrial appendage occlusion  (Coherex Medical Inc)
90
Coherex Medical Inc wavecrest i left atrial appendage occlusion
The <t>WaveCrest™</t> device (Coherex Medical, Salt Lake City, UT, USA).
Wavecrest I Left Atrial Appendage Occlusion, supplied by Coherex Medical Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atrial+appendage/pmc07377646-72-3-2?v=Coherex+Medical+Inc
Average 90 stars, based on 1 article reviews
wavecrest i left atrial appendage occlusion - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Pre-surgery echo of left atrial appendage

Journal: International Journal of Preventive Medicine

Article Title: Left Atrial Appendage Occlusion

doi:

Figure Lengend Snippet: Pre-surgery echo of left atrial appendage

Article Snippet: Recently, two devices specifically designed for percutaneous trans-catheter LAA occlusion have been introduced: the percutaneous LAA trans-catheter occlusion (PLAATO; Appriva Medical Inc) and WATCHMAN LAA system (Atritech, Inc).

Techniques:

Post-surgery echo of left atrial appendage

Journal: International Journal of Preventive Medicine

Article Title: Left Atrial Appendage Occlusion

doi:

Figure Lengend Snippet: Post-surgery echo of left atrial appendage

Article Snippet: Recently, two devices specifically designed for percutaneous trans-catheter LAA occlusion have been introduced: the percutaneous LAA trans-catheter occlusion (PLAATO; Appriva Medical Inc) and WATCHMAN LAA system (Atritech, Inc).

Techniques:

Occlutech Plus LAA closure device and delivery system. (A) The modified Occlutech LAA closure device consists of a proximal (PU membrane covered) and a distal (nitinol mesh) part. Distal positioned loops and newly developed anchors situated between the proximal and distal device parts secure anchoring within the LAA. The nitinol mesh has self-expanding properties ensuring self-modeling of the device within the LAA. The polyurethane (PU) covering serves as barrier excluding blood flow from the LA to the LAA. The connection hub serves as docking for the delivery system. B) Comparison of new device characteristics compared to the predecessor. C) Delivery system: the dilator (1) made from smooth conformable low friction radio-opaque material is inserted into the steerable delivery sheet (2) consisting of a thin braided wall and a soft flexible tip allowing bidirectional deflection up to 180°. The sheath has a hemostatic valve and can be connected by an adapter to the loader (4) made of transparent low friction material to allow inspection for air bubbles after pulling the occluder into the loader. Permission for usage of the image granted by OCCLUTECH Holding AG.

Journal: Scientific Reports

Article Title: Preclinical assessment of a modified Occlutech left atrial appendage closure device in a porcine model

doi: 10.1038/s41598-021-82359-1

Figure Lengend Snippet: Occlutech Plus LAA closure device and delivery system. (A) The modified Occlutech LAA closure device consists of a proximal (PU membrane covered) and a distal (nitinol mesh) part. Distal positioned loops and newly developed anchors situated between the proximal and distal device parts secure anchoring within the LAA. The nitinol mesh has self-expanding properties ensuring self-modeling of the device within the LAA. The polyurethane (PU) covering serves as barrier excluding blood flow from the LA to the LAA. The connection hub serves as docking for the delivery system. B) Comparison of new device characteristics compared to the predecessor. C) Delivery system: the dilator (1) made from smooth conformable low friction radio-opaque material is inserted into the steerable delivery sheet (2) consisting of a thin braided wall and a soft flexible tip allowing bidirectional deflection up to 180°. The sheath has a hemostatic valve and can be connected by an adapter to the loader (4) made of transparent low friction material to allow inspection for air bubbles after pulling the occluder into the loader. Permission for usage of the image granted by OCCLUTECH Holding AG.

Article Snippet: The results of this study indicate that implantation of a modified Occlutech LAA closure device is feasible with rapid endothelialization and low inflammatory infiltration in a porcine model. Human data are needed to further characterize safety and efficacy.

Techniques: Modification

Technical properties of LAA closure during follow-up.

Journal: Scientific Reports

Article Title: Preclinical assessment of a modified Occlutech left atrial appendage closure device in a porcine model

doi: 10.1038/s41598-021-82359-1

Figure Lengend Snippet: Technical properties of LAA closure during follow-up.

Article Snippet: The results of this study indicate that implantation of a modified Occlutech LAA closure device is feasible with rapid endothelialization and low inflammatory infiltration in a porcine model. Human data are needed to further characterize safety and efficacy.

Techniques: Coagulation

Technical properties of LAA closure during follow-up.

Journal: Scientific Reports

Article Title: Preclinical assessment of a modified Occlutech left atrial appendage closure device in a porcine model

doi: 10.1038/s41598-021-82359-1

Figure Lengend Snippet: Technical properties of LAA closure during follow-up.

Article Snippet: The modified Occlutech left atrial appendage closure device (Occlutech, Jena, Germany) consists of a conical-shaped, self-expandable Nitinol wire mesh that adapts to the shape of the LAA (Fig. ).

Techniques: Coagulation

The WaveCrest™ device (Coherex Medical, Salt Lake City, UT, USA).

Journal: The Journal of Innovations in Cardiac Rhythm Management

Article Title: Left Atrial Appendage Anatomy: Implications for Endocardial Catheter-based Device Closure

doi: 10.19102/icrm.2020.110704

Figure Lengend Snippet: The WaveCrest™ device (Coherex Medical, Salt Lake City, UT, USA).

Article Snippet: In the Coherex WAVECREST I Left Atrial Appendage Occlusion Study, the initial experience with this device involving 73 patients with a successful implantation rate of 96% was reported.

Techniques: